Lecture 19: Frontotemporal Dementia Flashcards
What is FTD?
Frontotemporal dementia: a group of disorders that cause progressive nerve cell loss in the frontal and temporal lobes of the brain.
What is the age range of individual diagnosed with FTD?
45-65 years
-most common in younger people
-50,000 - 60,000 people with FTD in US
Which are the types of FTD?
-behavior variant FTD
-primary progressive aphasia (PPA)
—-> semantic variant PPA
—-> non-fluent variant PPA
What are the characteristics of behavior variant FTD?
bvFTA: changes in personality including apathy, socially inappropriate activities, loss of empathy, poor decision making and judgement.
EX: Phineas Gage had an accident but became aggressive so he was the first look at how damage to the frontal lobe affects a person.
What are the characteristics of PPA?
problems with speaking, writing or comprehension this is due to the degeneration of the temporal lobe.
What are the characteristics of svPPA?
trouble understanding the meaning of words, finding words or naming people and objects.
What are the characteristics of nfvPPA?
difficulty producing speech and/or omitting words, using incorrect tenses or word endings.
-People affected tend to speak like children often.
What two proteins are the primary cause of FTD?
Tau and TDP-43 are associated with the cause of FTD due to abnormal accumulation in the brain
FTD cases are familial. Which genes are affected by these mutations?
-C9orf72
-Progranulin (GRN)
-Tau (MAPT)
Many genes implicated in FTD are also involved in which other disease?
ALS
Progranulin (GRN) is predominately expressed by __
microglia
Tau (MAPT) is expressed by _
neurons
What kind of protein is progranulin ?
lysosomal protein
What do reduced GRN levels cause?
-homozygous GRN mutations in lysosomal storage disease
-heterozygous GRN mutations in FTLD
-GRN SNP associated to neuro degeneration
What do increased GRN levels cause ?
-bio marker for cancer invasion and metastasis
-bio marker for metabolic disease
-bio marker for neuro inflammation
-bio marker for disease activity in auto immune disease